These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 26651304

  • 41. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
    Adam MK, Covert DJ, Stepien KE, Han DP.
    Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
    [Abstract] [Full Text] [Related]

  • 42. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
    Agarwal P, Wong YH, Dasgupta E, Agarwal R, Livingstone BI, Ramamurthy S, Chyn GS.
    Cutan Ocul Toxicol; 2015 May; 34(3):179-84. PubMed ID: 25068998
    [Abstract] [Full Text] [Related]

  • 43. Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.
    Jivrajka RV, Genead MA, McAnany JJ, Chow CC, Mieler WF.
    Eye (Lond); 2013 Sep; 27(9):1044-52. PubMed ID: 23764990
    [Abstract] [Full Text] [Related]

  • 44. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS, Severns ML.
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [Abstract] [Full Text] [Related]

  • 45. Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.
    Allahdina AM, Stetson PF, Vitale S, Wong WT, Chew EY, Ferris FL, Sieving PA, Cukras C.
    Invest Ophthalmol Vis Sci; 2018 Apr 01; 59(5):1953-1963. PubMed ID: 29677357
    [Abstract] [Full Text] [Related]

  • 46. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY, Chan WM, Li H, Lai RY, Lam DS.
    Am J Ophthalmol; 2005 Nov 01; 140(5):794-807. PubMed ID: 16310457
    [Abstract] [Full Text] [Related]

  • 47. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S, Kellner U.
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar 01; 250(3):319-25. PubMed ID: 22215255
    [Abstract] [Full Text] [Related]

  • 48. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT.
    Yülek F, Uğurlu N, Akçay E, Kocamış Sİ, Gerçeker S, Erten Ş, Midillioğlu İ, Şimşek Ş.
    Cutan Ocul Toxicol; 2013 Sep 01; 32(3):204-9. PubMed ID: 23351071
    [Abstract] [Full Text] [Related]

  • 49. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
    Debellemanière G, Flores M, Tumahai P, Meillat M, Bidaut Garnier M, Delbosc B, Saleh M.
    Acta Ophthalmol; 2015 Nov 01; 93(7):e534-40. PubMed ID: 25989823
    [Abstract] [Full Text] [Related]

  • 50. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O, Uchida A, Singh RP, Beven L, Hu M, Kaiser S, Srivastava SK, Ehlers JP.
    Br J Ophthalmol; 2019 Jan 01; 103(1):3-7. PubMed ID: 30190364
    [Abstract] [Full Text] [Related]

  • 51. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine.
    Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW, Fung WE, Oxford KW.
    Retina; 2003 Aug 01; 23(4):503-12. PubMed ID: 12972762
    [Abstract] [Full Text] [Related]

  • 52. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity.
    Tsang A, Kanda P, Gottlieb C, Virgili G, Kantungane L, Coupland S.
    Doc Ophthalmol; 2022 Apr 01; 144(2):117-124. PubMed ID: 34762206
    [Abstract] [Full Text] [Related]

  • 53. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB, Marmor MF.
    JAMA Ophthalmol; 2014 Dec 01; 132(12):1453-60. PubMed ID: 25275721
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC, Lima de Carvalho JR, Parmann R, Amaro-Quireza L, Lee W, Hood DC, Tsang SH, Sparrow JR.
    Invest Ophthalmol Vis Sci; 2020 Sep 01; 61(11):41. PubMed ID: 32976563
    [Abstract] [Full Text] [Related]

  • 58. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF.
    Retina; 2016 Oct 01; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract] [Full Text] [Related]

  • 59. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ.
    Am J Ophthalmol; 2013 Mar 01; 155(3):418-428.e1. PubMed ID: 23218706
    [Abstract] [Full Text] [Related]

  • 60. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
    Jayakar G, De Silva T, Cukras CA.
    Invest Ophthalmol Vis Sci; 2022 Jan 03; 63(1):15. PubMed ID: 35015028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.